Rare cutaneous lichen planus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254370
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare cutaneous lichen planus refers to uncommon clinical variants of lichen planus that primarily affect the skin. Lichen planus is an inflammatory condition mediated by the immune system, and while classic cutaneous lichen planus is relatively common, certain morphological subtypes are considered rare. These rare variants may include forms such as lichen planus pemphigoides, lichen planus pigmentosus, atrophic lichen planus, annular lichen planus, linear lichen planus, and other unusual presentations. The condition primarily affects the integumentary system (skin), and depending on the variant, may present with distinctive papules, plaques, pigmentary changes, blistering, or atrophic lesions that differ from the classic violaceous, polygonal, pruritic papules typically seen in common lichen planus. The exact cause of rare cutaneous lichen planus remains incompletely understood, but it is believed to involve a T-cell-mediated autoimmune response directed against basal keratinocytes in the skin. Triggers may include medications, infections, contact allergens, and other environmental factors, though in many cases no specific trigger is identified. Diagnosis is typically made through clinical examination and confirmed by skin biopsy, which characteristically shows a band-like lymphocytic infiltrate at the dermoepidermal junction with damage to basal keratinocytes. Treatment options for rare cutaneous lichen planus are largely similar to those for classic lichen planus and include topical corticosteroids as first-line therapy, topical calcineurin inhibitors, phototherapy (particularly narrowband UVB or PUVA), and systemic therapies such as oral corticosteroids, retinoids, methotrexate, or other immunosuppressive agents for more severe or refractory cases. The condition may be self-limiting in some patients, though certain rare variants can be more persistent or difficult to treat. Management is generally symptomatic, aimed at reducing inflammation, relieving pruritus, and preventing complications such as post-inflammatory hyperpigmentation or scarring.

Also known as:

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare cutaneous lichen planus.

View clinical trials →

No actively recruiting trials found for Rare cutaneous lichen planus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare cutaneous lichen planus community →

No specialists are currently listed for Rare cutaneous lichen planus.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare cutaneous lichen planus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare cutaneous lichen planusForum →

No community posts yet. Be the first to share your experience with Rare cutaneous lichen planus.

Start the conversation →

Latest news about Rare cutaneous lichen planus

No recent news articles for Rare cutaneous lichen planus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare cutaneous lichen planus

What is Rare cutaneous lichen planus?

Rare cutaneous lichen planus refers to uncommon clinical variants of lichen planus that primarily affect the skin. Lichen planus is an inflammatory condition mediated by the immune system, and while classic cutaneous lichen planus is relatively common, certain morphological subtypes are considered rare. These rare variants may include forms such as lichen planus pemphigoides, lichen planus pigmentosus, atrophic lichen planus, annular lichen planus, linear lichen planus, and other unusual presentations. The condition primarily affects the integumentary system (skin), and depending on the varian

How is Rare cutaneous lichen planus inherited?

Rare cutaneous lichen planus follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Rare cutaneous lichen planus typically begin?

Typical onset of Rare cutaneous lichen planus is adult. Age of onset can vary across affected individuals.